• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold.

作者信息

Anttila A K, Rasanen L, Leinonen E V

机构信息

Department of Psychiatry, Tampere University Hospital, Pitkäniemi, Finland.

出版信息

Ann Pharmacother. 2001 Oct;35(10):1221-3. doi: 10.1345/aph.1A014.

DOI:10.1345/aph.1A014
PMID:11675851
Abstract

OBJECTIVE

To report two cases of interaction between fluvoxamine and mirtazapine.

CASE SUMMARY

A 17-year-old boy was treated with mirtazapine 30 mg/d. The addition of fluvoxamine 100 mg/d to the regimen caused a threefold increase in the mirtazapine concentration. This interaction was associated with increased anxiety. A second patient, a 43-year-old woman, was treated with mirtazapine 15 mg/d. There was a fourfold increase in her mirtazapine concentration and simultaneous mood improvements after augmentation with fluvoxamine 50 mg/d.

DISCUSSION

This is the first report of any interaction between fluvoxamine and mirtazapine. Mirtazapine is mainly metabolized by cytochrome P450 isoenzymes CYP1A2, CYP2D6, and CYP3A4. Fluvoxamine and cimetidine Inhibit the same isoenzymes, but fluvoxamine is probably the only agent that causes a clinically significant interaction.

CONCLUSIONS

Adding fluvoxamine to treatment with mirtazapine may cause a significant increase in mirtazapine concentration. This interaction may necessitate adjustment of the mirtazapine dosage.

摘要

相似文献

1
Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold.
Ann Pharmacother. 2001 Oct;35(10):1221-3. doi: 10.1345/aph.1A014.
2
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.新型抗抑郁药与细胞色素P450系统:聚焦于文拉法辛、奈法唑酮和米氮平。
Depress Anxiety. 1998;7 Suppl 1:24-32.
3
Imipramine and mirtazapine are less effective than expected.丙咪嗪和米氮平的疗效低于预期。
Psychopharmacology (Berl). 1997 Feb;129(3):297-8. doi: 10.1007/s002130050195.
4
Non-fatal mirtazapine overdose.
Int Clin Psychopharmacol. 1998 Nov;13(6):277-9. doi: 10.1097/00004850-199811000-00007.
5
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
Eur Neuropsychopharmacol. 1999 Dec;10(1):51-7. doi: 10.1016/s0924-977x(99)00054-1.
6
Mirtazapine and breastfeeding: maternal and infant plasma levels.米氮平与母乳喂养:母婴血浆水平
Am J Psychiatry. 2007 Feb;164(2):348-9. doi: 10.1176/ajp.2007.164.2.348a.
7
Mirtazapine enantiomers in blood and cerebrospinal fluid.
Neuropsychobiology. 2006;54(3):179-81. doi: 10.1159/000098654. Epub 2006 Jan 17.
8
Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.文拉法辛联合米氮平作为忧郁症的一线治疗:初步结果
J Psychopharmacol. 2010 Dec;24(12):1837. doi: 10.1177/0269881110376696.
9
Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.临床实践中米氮平剂量、血药浓度、疗效及副作用之间的关系。
Pharmacopsychiatry. 2005 May;38(3):113-7. doi: 10.1055/s-2005-864120.
10
A review of the pharmacological and clinical profile of mirtazapine.米氮平的药理学与临床概况综述。
CNS Drug Rev. 2001 Fall;7(3):249-64. doi: 10.1111/j.1527-3458.2001.tb00198.x.

引用本文的文献

1
Drug-Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes.涉及肠道和肝脏CYP1A酶的药物相互作用。
Pharmaceutics. 2020 Dec 11;12(12):1201. doi: 10.3390/pharmaceutics12121201.
2
Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model.在离体灌注大鼠肝脏模型中,摇头丸(3,4-亚甲基二氧甲基苯丙胺,MDMA)对米氮平代谢的抑制作用。
Daru. 2017 Jun 28;25(1):16. doi: 10.1186/s40199-017-0183-z.
3
Clinically significant drug interactions with newer antidepressants.与新型抗抑郁药相关的具有临床意义的药物相互作用。
CNS Drugs. 2012 Jan 1;26(1):39-67. doi: 10.2165/11594710-000000000-00000.
4
Getting the balance right: Established and emerging therapies for major depressive disorders.把握平衡:治疗重度抑郁症的既有和新兴疗法。
Neuropsychiatr Dis Treat. 2010 Sep 7;6:343-64. doi: 10.2147/ndt.s10485.
5
Mirtazapine: a review of its use in major depression and other psychiatric disorders.米氮平:对其在重度抑郁症及其他精神障碍中的应用综述
CNS Drugs. 2009;23(5):427-52. doi: 10.2165/00023210-200923050-00006.
6
Population pharmacokinetic analysis of mirtazapine.米氮平的群体药代动力学分析。
Eur J Clin Pharmacol. 2004 Sep;60(7):473-80. doi: 10.1007/s00228-004-0737-0.